Study of CTGF protein in urine for enlarged prostate blockage
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial looks at a protein called CTGF in urine to find out if it can help diagnose blockage from an enlarged prostate. It may help men with this condition who plan to have surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man over the age of 40
- You have an enlarged prostate causing a blockage (with or without a catheter)
- You are scheduled for surgery to treat the blockage
- Your PSA (prostate test) level is 2.5 or lower
- You do not have diabetes, a history of prostate or bladder cancer, or neurological conditions like Parkinson's or multiple sclerosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a better way to manage benign prostatic hyperplasia (BPH) by using your answers to regular health questionnaires. It may help your care team make more informed decisions about your symptoms and treatment over time.
This trial tests a focused ultrasound treatment for benign prostatic hyperplasia (BPH), which is a non-cancerous enlargement of the prostate. It aims to see if HIFU can safely relieve symptoms like weak urine flow and frequent urination.
This trial tests a new device called the FloStent, a small tube placed in the urine channel to help men with an enlarged prostate pee more easily. It's for men who have moderate to severe symptoms and haven't had prostate surgery before.
This study looks at two natural substances in urine (BDNF and NGF) to see if they can help doctors understand how the lower urinary tract is working in men with an enlarged prostate. It is a simple, non-invasive test that may lead to better ways to diagnose and treat bladder problems.
This trial is testing if a simple urine test can help track prostate or bladder cancer over time without needing invasive procedures. It includes five specific patient groups with different stages of these cancers.
This study looks for urine markers (proteins and metabolites) that may help predict how prostate cancer patients respond to treatment and what their outcomes are. You may be asked to give a urine sample and allow use of your medical and treatment details for analysis (results are not shared with you).
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.